BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33253326)

  • 1. Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.
    Xu X; Ramanujam M; Visvanathan S; Assassi S; Liu Z; Li L
    PLoS One; 2020; 15(11):e0242863. PubMed ID: 33253326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compendium of skin molecular signatures identifies key pathological features associated with fibrosis in systemic sclerosis.
    Moon SJ; Bae JM; Park KS; Tagkopoulos I; Kim KJ
    Ann Rheum Dis; 2019 Jun; 78(6):817-825. PubMed ID: 30952646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis.
    Denton CP; Ong VH; Xu S; Chen-Harris H; Modrusan Z; Lafyatis R; Khanna D; Jahreis A; Siegel J; Sornasse T
    Ann Rheum Dis; 2018 Sep; 77(9):1362-1371. PubMed ID: 29853453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis.
    Taroni JN; Greene CS; Martyanov V; Wood TA; Christmann RB; Farber HW; Lafyatis RA; Denton CP; Hinchcliff ME; Pioli PA; Mahoney JM; Whitfield ML
    Genome Med; 2017 Mar; 9(1):27. PubMed ID: 28330499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems level analysis of systemic sclerosis shows a network of immune and profibrotic pathways connected with genetic polymorphisms.
    Mahoney JM; Taroni J; Martyanov V; Wood TA; Greene CS; Pioli PA; Hinchcliff ME; Whitfield ML
    PLoS Comput Biol; 2015 Jan; 11(1):e1004005. PubMed ID: 25569146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis.
    Assassi S; Swindell WR; Wu M; Tan FD; Khanna D; Furst DE; Tashkin DP; Jahan-Tigh RR; Mayes MD; Gudjonsson JE; Chang JT
    Arthritis Rheumatol; 2015 Nov; 67(11):3016-26. PubMed ID: 26238292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low RUNX3 expression alters dendritic cell function in patients with systemic sclerosis and contributes to enhanced fibrosis.
    Affandi AJ; Carvalheiro T; Ottria A; Broen JC; Bossini-Castillo L; Tieland RG; Bon LV; Chouri E; Rossato M; Mertens JS; Garcia S; Pandit A; de Kroon LM; Christmann RB; Martin J; van Roon JA; Radstake TR; Marut W
    Ann Rheum Dis; 2019 Sep; 78(9):1249-1259. PubMed ID: 31126957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited cutaneous systemic sclerosis skin demonstrates distinct molecular subsets separated by a cardiovascular development gene expression signature.
    Derrett-Smith EC; Martyanov V; Chighizola CB; Moinzadeh P; Campochiaro C; Khan K; Wood TA; Meroni PL; Abraham DJ; Ong VH; Lafyatis R; Whitfield ML; Denton CP
    Arthritis Res Ther; 2017 Jul; 19(1):156. PubMed ID: 28676069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular stratification and precision medicine in systemic sclerosis from genomic and proteomic data.
    Martyanov V; Whitfield ML
    Curr Opin Rheumatol; 2016 Jan; 28(1):83-8. PubMed ID: 26555452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell Type-Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits.
    Berkowitz JS; Tabib T; Xiao H; Sadej GM; Khanna D; Fuschiotti P; Lafyatis RA; Das J
    Arthritis Rheumatol; 2023 Oct; 75(10):1819-1830. PubMed ID: 37096444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
    Wu M; Skaug B; Bi X; Mills T; Salazar G; Zhou X; Reveille J; Agarwal SK; Blackburn MR; Mayes MD; Assassi S
    Ann Rheum Dis; 2019 Nov; 78(11):1583-1591. PubMed ID: 31439591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of TLR7, TLR9, JAK2, and STAT3 genes in peripheral blood mononuclear cells from patients with systemic sclerosis.
    Vreća M; Zeković A; Damjanov N; Andjelković M; Ugrin M; Pavlović S; Spasovski V
    J Appl Genet; 2018 Feb; 59(1):59-66. PubMed ID: 29147913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis.
    Franks JM; Toledo DM; Martyanov V; Wang Y; Huang S; Wood TA; Spino C; Chung L; Denton CP; Derrett-Smith E; Gordon JK; Spiera R; Domsic R; Hinchcliff M; Khanna D; Whitfield ML
    Rheumatology (Oxford); 2022 Dec; 62(1):19-28. PubMed ID: 35751592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulator combinations identify systemic sclerosis patients with more severe disease.
    Wang Y; Franks JM; Yang M; Toledo DM; Wood TA; Hinchcliff M; Whitfield ML
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32721949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvovirus B19 activates in vitro normal human dermal fibroblasts: a possible implication in skin fibrosis and systemic sclerosis.
    Arvia R; Margheri F; Stincarelli MA; Laurenzana A; Fibbi G; Gallinella G; Ferri C; Del Rosso M; Zakrzewska K
    Rheumatology (Oxford); 2020 Nov; 59(11):3526-3532. PubMed ID: 32556240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular signatures in skin associated with clinical improvement during mycophenolate treatment in systemic sclerosis.
    Hinchcliff M; Huang CC; Wood TA; Matthew Mahoney J; Martyanov V; Bhattacharyya S; Tamaki Z; Lee J; Carns M; Podlusky S; Sirajuddin A; Shah SJ; Chang RW; Lafyatis R; Varga J; Whitfield ML
    J Invest Dermatol; 2013 Aug; 133(8):1979-89. PubMed ID: 23677167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic approach to understanding the pathogenesis of systemic sclerosis.
    Zuo X; Zhang L; Luo H; Li Y; Zhu H
    Clin Genet; 2017 Oct; 92(4):365-371. PubMed ID: 27918067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?
    Assassi S; Mayes MD
    Curr Opin Rheumatol; 2013 Nov; 25(6):686-91. PubMed ID: 24061076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
    Korman B
    Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.